Whitehawk Therapeutics (WHWK) Shares Outstanding (Weighted Average) (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Shares Outstanding (Weighted Average) of $69.2 million for Q1 2026, up 74.66% year-over-year from $39.6 million in Q1 2025, and up 244.87% on a QoQ basis from $20.1 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $69.2 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 74.66% year-over-year to $69.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.2 million (up 74.66% YoY) and the FY2025 annual result came in at $20.1 million, down 25.72% from the prior year.
- Shares Outstanding (Weighted Average) advanced to $69.2 million in Q1 2026 per WHWK's latest filing, from $20.1 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $69.2 million in Q1 2026 and bottomed at $29166.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $22.5 million (2022), against an average of $23.2 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) plunged 99.94%; it then jumped 92612.06% in 2024.
- Tracing WHWK's Shares Outstanding (Weighted Average) over 5 years: stood at $22.5 million in 2022, then plunged by 99.87% to $29167.0 in 2023, then soared by 92573.03% to $27.0 million in 2024, then retreated by 25.72% to $20.1 million in 2025, then jumped by 244.87% to $69.2 million in 2026.
- Per Business Quant, the three latest WHWK Shares Outstanding (Weighted Average) figures stand at $69.2 million (Q1 2026), $20.1 million (Q4 2025), and $59.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | 69.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.24 Mn |
| Dec 31, 2025 | 20.08 Mn |
| Sep 30, 2025 | 59.42 Mn |
| Jun 30, 2025 | 54.44 Mn |
| Mar 31, 2025 | 39.64 Mn |
| Dec 31, 2024 | 27.03 Mn |
| Sep 30, 2024 | 27.04 Mn |
| Jun 30, 2024 | 27.00 Mn |
| Mar 31, 2024 | 26.98 Mn |
| Dec 31, 2023 | 29,167.00 |
| Sep 30, 2023 | 29,167.00 |
| Jun 30, 2023 | 29,167.00 |
| Mar 31, 2023 | 29,167.00 |
| Dec 31, 2022 | 22.51 Mn |
| Sep 30, 2022 | 21.27 Mn |
| Jun 30, 2022 | 29,166.00 |
| Mar 31, 2022 | 29,166.00 |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 4.89 Mn |
| Jun 30, 2021 | 2.54 Mn |
| Mar 31, 2021 | 47.28 Mn |
| Jun 30, 2020 | 40.59 Mn |
| Mar 31, 2020 | 40.59 Mn |
| Dec 31, 2019 | 40.59 Mn |
| Sep 30, 2019 | 40.59 Mn |
| Jun 30, 2019 | 40.59 Mn |
| Mar 31, 2019 | 40.59 Mn |
| Dec 31, 2018 | 33.93 Mn |
| Sep 30, 2018 | 40.53 Mn |
| Jun 30, 2018 | 27.19 Mn |
| Mar 31, 2018 | 27.05 Mn |
| Dec 31, 2017 | 21.67 Mn |
| Sep 30, 2017 | 26.93 Mn |
| Jun 30, 2017 | 26.90 Mn |
| Mar 31, 2017 | 5.61 Mn |
| Dec 31, 2016 | 961,482.00 |
| Sep 30, 2016 | 888,094.00 |
| Jun 30, 2016 | 823,097.00 |
| Mar 31, 2016 | 737,016.00 |
| Dec 31, 2015 | 5.00 Mn |
| Sep 30, 2015 | 5.00 Mn |
| Jun 30, 2015 | 5.00 Mn |
| Mar 31, 2015 | 5.00 Mn |
| Dec 31, 2014 | 5.00 Mn |
| Sep 30, 2014 | 5.00 Mn |
| Jun 30, 2014 | 5.00 Mn |
| Mar 31, 2014 | 5.00 Mn |
| Dec 31, 2013 | 5.00 Mn |
| Sep 30, 2013 | 5.00 Mn |
| Jun 30, 2013 | 5.00 Mn |
| Mar 31, 2013 | 5.00 Mn |
| Dec 31, 2012 | 5.00 Mn |
| Sep 30, 2012 | 5.00 Mn |
| Jun 30, 2012 | 5.00 Mn |
| Mar 31, 2012 | 5.00 Mn |
| Dec 31, 2011 | 5.00 Mn |
| Sep 30, 2011 | 5.00 Mn |
| Jun 30, 2011 | 5.00 Mn |
| Mar 31, 2011 | 5.00 Mn |
| Dec 31, 2010 | 5.00 Mn |
| Sep 30, 2010 | 5.00 Mn |